Nimbus

Nimbus Therapeutics

This clinical-stage biotechnology company develops small molecule medicines for patients with cancer, immunology, and metabolic diseases using an AI-enhanced computational discovery engine.

Endeavor BioMedicines

This clinical-stage biotechnology company develops small-molecule inhibitors and therapies for patients with oncology and fibrotic lung diseases.

Jnana Therapeutics

This clinical-stage biotechnology company develops small molecule medicines for patients with rare and immune-mediated diseases using a proprietary chemoproteomics drug discovery platform.

Enveda Bioscience

This company develops small molecule medicines for patients with inflammatory and metabolic diseases by using machine learning to map natural plant chemistry.

Rivus Pharmaceuticals

The company develops oral small-molecule medicines for patients with obesity and associated cardiometabolic diseases including heart failure and type 2 diabetes.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

Congruence Therapeutics

This biotechnology company develops small molecule medicines for patients with metabolic, neurological, immunological and oncological diseases using machine learning and biophysics.

Iambic

This company develops small molecule medicines for patients with cancer using an artificial intelligence drug discovery platform.